Novel Tricyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches

ACS Medicinal Chemistry Letters 2026 Open access

Read full text
Authors: Ram W. Sabnis, Anika R. Sabnis
DOI: 10.1021/acsmedchemlett.6c00235
Cited by: 3
References: 6

Abstract

High Resolution Image Download MS PowerPoint Slide Provided herein are novel tricyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse and headaches, and processes for preparing such compounds.

Fields of Study & Subjects

Neurotransmitter Receptor Influence on Behavior Psychedelics and Drug Studies Nicotinic Acetylcholine Receptors Study

Publication details

Journal / source
ACS Medicinal Chemistry Letters
Publisher
American Chemical Society (ACS)
Volume
17
Issue
6
Pages
1234–1235
Publication date
7 May 2026
Language
EN